Brief: Akari Therapeutics Granted FDA Rare Pediatric Disease Designation Of Nomacopan

Akari Therapeutics

10/11/2022 13:22

Nov 10 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS GRANTED FDA RARE PEDIATRIC DISEASE
DESIGNATION OF NOMACOPAN FOR THE TREATMENT OF PEDIATRIC HSCT-TMA

Source text for Eikon:  ID:nGNE7rHxQl 
Further company coverage:  AKTX.O 
 ((reuters.briefs@thomsonreuters.com;))